• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TORAX MEDICAL, INC. 1.5T LINX, 15B; ANTI-REFLUX IMPLANT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TORAX MEDICAL, INC. 1.5T LINX, 15B; ANTI-REFLUX IMPLANT Back to Search Results
Catalog Number LXMC15
Device Problems Device Appears to Trigger Rejection (1524); Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Dysphagia/ Odynophagia (1815); Cramp(s) /Muscle Spasm(s) (4521)
Event Date 11/09/2023
Event Type  Injury  
Event Description
It was reported that a linx removal for re-think study patient: (b)(6).Linx was electively removed on (b)(6) 2023 due to issues the patient developed with worsening esophageal spasm and jackhammer esophagus following implant of the linx device.The linx was removed robotically without incident.Date of original implant was on (b)(6) 2023.Hospital of linx implant: methodist specialty and transplant hospital.Symptoms of esophageal spasm were first reported on (b)(6) 2023.She had a subsequent follow up on (b)(6) 2023 in which spasm was significantly worse and was affecting oral intake.Medical interventions: patient was started on valium for esophageal spasm and given a medrol dosepak after her first follow up appointment on (b)(6) 2023.Patient called back with worsening symptoms and inability to tolerate valium so she was transitioned to methocarbamol and levsin with no improvement.After esophageal spasm was worsening and patient began to struggle with oral intake then on (b)(6) 2023 she was started on peppermint oil and a calcium channel blocker and started on iv fluid infusions to prevent dehydration.She underwent a barium upper gi esophagram that showed the linx was in good position.The contrast completely cleared the linx after 3 peristaltic waves.Patient followed up on (b)(6) 2023 with ongoing issues with esophageal spasm and another medrol dosepak was prescribed.She followed up with her gastroenterologist who performed an egd and dilation of the linx which had no effect on the symptoms.He repeated esophageal manometry which showed multiple swallows with dci >8000 consistent with jackhammer esophagus.I discussed the case at length with her gastroenterologist on (b)(6) 2023 and we agreed that with the worsening jackhammer esophagus symptoms and her failure to respond to treatments she would likely require explant.We opted to give her another 6 weeks to see if the symptoms would improve.She underwent cardiac evaluation and clearance to ensure there was no cardiac component to her symptoms.That workup included ekg, echocardiogram, exercise stress test, and 72 hour halter monitor and no unusual events were found.Patient followed up on (b)(6) 2023 with minimal improvement in symptoms and requested to move forward with explant.Explant occurred on (b)(6) 2023.None of the testing showed a discontinued linx or any abnormality with the device its self.
 
Manufacturer Narrative
(b)(4).Date sent: 1/2/2024.Attempts have been made to retrieve the device.To date the device has not been returned.If the device or further details are received at a later date a supplemental medwatch will be sent.Lot number was received and dhr is pending review.When the review is completed, a supplemental medwatch will be sent with a summary of the evaluation.Attempts are being made to obtain the following information.To date no response has been provided.If further details are received at a later date a supplemental medwatch will be sent: prior to linx placement, did the patient have an egd, ph, and manometry studies done? if yes, could you please share the results? when using the linx sizing device what technique was used to determine the size? did the patient have an autoimmune disease? is the patient currently taking steroids / immunosuppressive drugs? did the patient have any pre-existing dysphagia or other conditions (other than gerd)? how severe was the dysphagia/odynophagia before intervention? were there any intra-operative complications during implant? was there any hiatal or crural repair done at the same time as the implant? were there any other contributing factors that led to the removal of the device other than the reported dysphagia and muscle spasms? besides the reported dysphagia and muscle spasms, what was the reason for removal of the linx device? was the device found in the correct position/geometry at the time of removal? this report is being submitted pursuant to the provisions of 21 cfr, part 803.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by ethicon, or its employees that the report constitutes an admission that the product, ethicon, or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.
 
Manufacturer Narrative
(b)(4).Date sent: 2/5/2024.
 
Manufacturer Narrative
(b)(4) date sent: 2/13/2024 investigation summary a washer was noted to be disconnected from a bead case.The washer was observed to be bent outwards and weld tracks are visible on both the washer and bead case.These findings suggest that the washer was pulled out of the bead case due to external forces applied during an explant procedure.The remaining device characteristics, excepting the issues called out above, show no anomalies for a device that has been reasonably changed as part of the explant procedure and significant tooling marks were noted in some beads.Link length and tensile force were found to meet the applicable specifications.Overall, no analysis conclusions relevant to the patient experience were found.A manufacturing record evaluation was performed for the finished device 27613 number, and no non-conformances related to the malfunction were identified.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
1.5T LINX, 15B
Type of Device
ANTI-REFLUX IMPLANT
Manufacturer (Section D)
TORAX MEDICAL, INC.
4545 creek road
cincinnati OH
Manufacturer Contact
kate karberg
4545 creek rd.
cincinnati, OH 45242
3035526892
MDR Report Key18425648
MDR Text Key331859328
Report Number3008766073-2024-00002
Device Sequence Number1
Product Code LEI
UDI-Device Identifier00855106005356
UDI-Public00855106005356
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P100049
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Company Representative
Reporter Occupation Other
Type of Report Initial,Followup,Followup
Report Date 02/13/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue NumberLXMC15
Device Lot Number27613
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? No
Initial Date Manufacturer Received 12/16/2023
Initial Date FDA Received01/02/2024
Supplement Dates Manufacturer Received01/23/2024
02/12/2024
Supplement Dates FDA Received02/05/2024
02/13/2024
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured07/24/2020
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? Yes
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age46 YR
Patient SexFemale
Patient Weight85 KG
-
-